Share on LinkedInShare on LinkedIn

ARTICLE · 15 AUGUST 2018

Patenting Artificial Intelligence: Issues Of Obviousness, Inventorship, And Patent Eligibility

Finnegan, Henderson, Farabow, Garrett & Dunner LLP
Finnegan, Henderson, Farabow, Garrett & Dunner LLP
Contributor
Finnegan, Henderson, Farabow, Garrett & Dunner LLP

Finnegan, Henderson, Farabow, Garrett & Dunner LLP

Finnegan, Henderson, Farabow, Garrett & Dunner LLP is one of the world’s largest firms focusing on...

View firm profile
Explore more from Finnegan, Henderson, Farabow, Garrett & Dunner LLP

Artificial intelligence (AI) is rapidly transforming the world of medicine, as the recent decades have marked a surge in the development of medical AI.

United StatesIntellectual Property

Artificial intelligence ("AI") is rapidly transforming the world of medicine, as the recent decades have marked a surge in the development of medical AI.1 These thinking machines are now used in diagnosis, treatment, and drug development. As the technology advances, so too must our understanding of patent law and patent protection. The use of AI in these fields raises several issues, all hinging on the question of personhood and human contributions, affecting both inventorship (and ownership) and patentability (including subject matter eligibility and predictability). This article addresses these questions in turn after addressing the recent advances in medical AI.

Artificial Intelligence in Medicine

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

See more popular content from